Corona lockdown has forced Ullern students to study from home via digital classes.
Important cancer research into gene-editing human embryos will now be possible in Norway
Meet our new member Adjutec Pharma, a company with new technology against multi-drug resistant bacteria.
Helsenæringen er en dobbel mulighet for Norge.
Bemcentinib from the Norwegian biotech BerGenBio will be tested on COVID-19 patients.
Adapting cancer-fighting artificial intelligence technology to combat COVID-19.